Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco.  Your success is our priority, so we don’t just send some money and ''check in'' at board meetings. Our mission is to empower you with game-changing support through every stage of your journey.  Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one.  You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.

Speedinvest

Norrsken VC is a Stockholm-based impact VC fund investing in start-ups solving the world's biggest problems while building massive businesses

Norrsken VC

Dieter von Holtzbrinck Ventures (DvH Ventures) is one of the leading European early-stage investors. As an independent venture capitalist, DvH Ventures invests in young technology companies, building successful investment clusters in areas such as digital health, education and fintech. In addition to capital, DvH Ventures supports companies with management expertise and an international investor network. An exclusive media-for-equity program also offers access to strong brands such as Handelsblatt, DIE ZEIT, WirtschaftsWoche and Apotheken Umschau, and thus an enormous reach into the respective target groups. DvH Ventures was founded in 2014 and today manages various venture capital funds from its offices in Cologne and Vienna. Managing partners are Peter Richarz and Fabian von Trotha.

DvH Ventures

The SoftBank Vision Fund Emerge program, in partnership with Speedinvest, promotes diversity in tech and entrepreneurship by partnering underrepresented founders with the capital, tools, and network they need to scale their business. This year’s program is open to European founders, with participation from some of Europe’s leading seed investors: Breega, Kindred, Cherry Ventures, and firstminute Capital.

SoftBank Vision Fund Emerge Program

juli

Dedicated to your health. We're a digital healthcare startup on a worldwide mission to improve the lives of people with chronic conditions. We're really good at analyzing data and want to use this superpower to change healthcare for the better. There’s great potential within all the health data we're all already collecting about ourselves. We at juli strive to bring it all together! juli was founded in 2020, right at the start of the COVID-19 pandemic by a group of people that wanted to use their knowledge about big data for a better cause. Some of the founders suffer from a chronic condition themselves and have been on the lookout for many years to find out what triggers episodes and what helps to get better.  Learn more

juli is an AI-driven chronic care management platform that gathers biomarker data to identify triggers of difficult-to-treat chronic conditions and provides recommendations requiring micro behavioral changes. It gathers data from smartphones and wearables, environmental data, and electronic health records as well as patient-reported information specific to the condition. It combines and analyzes this data with AI and machine learning to give insights and recommendations to improve health. As of March 2022, the company had served nearly 15,000 patients via the juli app. The company covers chronic conditions such as asthma, depression, migraine, bipolar disorder, and chronic pain.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

Two clinical trials demonstrate efficacy of juli’s digital health app

<div>
 
 juli is an AI-driven chronic care management platform that gathers biomarker data to identify triggers of difficult-to-treat chronic conditions and provides recommendations requiring micro behavioral changes. It gathers data from smartphones and wearables, environmental data, and electronic health records as well as patient-reported information specific to the condition. It combines and analyzes this data with AI and machine learning to give insights and recommendations to improve health. As of March 2022, the company had served nearly 15,000 patients via the juli app. The company covers chronic conditions such as asthma, depression, migraine, bipolar disorder, and chronic pain. 
 
 
 The app uses both a passive and active approach to gathering information. Its AI gathers information passively from wearables while individuals can also actively provide information on their specific condition. Additionally, the app generates patterns and possible correlations between an individual’s disease and lifestyle. 
 
 
 The company was selected by the US Department of Health and Human Services as one of 15 digital health startups to join the 2022 PandemicX Accelerator cohort and one of the companies selected into SoftBank Vision Fund’s Emerge Program for 2021. juli operates a B2C and B2B2C business model and is free for use. The company may introduce a subscription model in both markets for additional services in the future.
 
 
 Its latest funding round took place in March 2022, where it raised USD 3.8 million in a seed funding round led by Speedinvest. The funds were allocated to expand its marketing team in the US, to build out its AI technology, and conduct clinical trials to evaluate the effectiveness of the app. 
 
</div>

juli is an AI-driven chronic care management platform that gathers biomarker data to identify triggers of difficult-to-treat chronic conditions and provides recommendations requiring micro behavioral changes. It gathers data from smartphones and wearables, environmental data, and electronic health records as well as patient-reported information specific to the condition. It combines and analyzes this data with AI and machine learning to give insights and recommendations to improve health. As of March 2022, the company had served nearly 15,000 patients via the juli app. The company covers chronic conditions such as asthma, depression, migraine, bipolar disorder, and chronic pain.The app uses both a passive and active approach to gathering information. Its AI gathers information passively from wearables while individuals can also actively provide information on their specific condition. Additionally, the app generates patterns and possible correlations between an individual’s disease and lifestyle.The company was selected by the US Department of Health and Human Services as one of 15 digital health startups to join the 2022 PandemicX Accelerator cohort and one of the companies selected into SoftBank Vision Fund’s Emerge Program for 2021. juli operates a B2C and B2B2C business model and is free for use. The company may introduce a subscription model in both markets for additional services in the future.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

juli

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless